Global Follicular Lymphoma Therapeutics Market 2018-2022

Gain compelling insights from Technavio’s market research report. Check out the latest facts about the follicular lymphoma treatment industry

The global follicular lymphoma therapeutics market is expected to grow at a CAGR of almost 8% during the forecast period

Follicular lymphoma therapeutics industry growth is expected to accelerate massively over the next five years as top pharmaceutical companies are offering patient support programs to increase awareness about the treatment and range of cost. The Americas will drive almost 43% of the growth for the global follicular lymphoma therapeutics market, while EMEA and APAC are also predicted to make valuable contributions to the incremental growth during the forecast period. Continuous research is being conducted to develop advanced technology for the diagnosis of follicular lymphoma to provide accurate results, which is expected to fuel the demand for follicular lymphoma treatment. Technavio’s follicular lymphoma therapeutics industry analysis reveals promising markets around the world.

Want a bigger picture? Get a free sample of this report now!

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Increasing government initiatives is driving the market growth

The global follicular lymphoma therapeutics market is likely to be driven by a rise in government-funded initiatives such as Cancer Breakthroughs 2020 in the US. The number of pipeline molecules being developed for follicular lymphoma treatment is rising significantly and there are multiple promising therapeutic agents for lymphoma treatment in the pipeline, which is expected to drive the demand for follicular lymphoma therapeutics across the globe. Also, the approval of new therapeutic agents broadens the available options for follicular lymphoma treatment will significantly contribute to the growth of the follicular lymphoma therapeutics industry over the next few years.

Get more value with Technavio’s subscription platform! Gain easy access to all Technavio’s reports, along with on-demand services. Start your 14-day FREE trial

Bayer, Biogen, and F. Hoffmann-La Roche are among the leading vendors in the follicular lymphoma therapeutics market

Most of the established companies in the follicular lymphoma therapeutics market are focused on engaging in strategic alliances to strengthen their market positions to gain a competitive advantage. At the end of 2017, biologicals dominated the global follicular lymphoma therapeutics market by product type with a share of over 56%, followed by small molecules. Many international and regional vendors are vying for their share of the market, and players must differentiate themselves to gain vital traction over their peers.

This report offers a complete analysis of several companies, including:

• Bayer
• Biogen
• F. Hoffmann-La Roche
• Gilead
• Merck

Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch